ClearBridge Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.8M | Sell |
2,140,577
-119,128
| -5% | -$4.33M | 0.06% | 258 |
|
|
2025
Q1 | $81.8M | Sell |
2,259,705
-62,500
| -3% | -$2.26M | 0.07% | 246 |
|
|
2024
Q4 | $97.7M | Sell |
2,322,205
-104,772
| -4% | -$4.41M | 0.08% | 236 |
|
|
2024
Q3 | $135M | Buy |
2,426,977
+73,173
| +3% | +$4.06M | 0.11% | 185 |
|
|
2024
Q2 | $96.7M | Sell |
2,353,804
-47,050
| -2% | -$1.93M | 0.08% | 234 |
|
|
2024
Q1 | $112M | Buy |
2,400,854
+17,362
| +0.7% | +$811K | 0.09% | 237 |
|
|
2023
Q4 | $114M | Buy |
2,383,492
+89,922
| +4% | +$4.3M | 0.1% | 216 |
|
|
2023
Q3 | $81.8M | Sell |
2,293,570
-469,676
| -17% | -$16.7M | 0.08% | 241 |
|
|
2023
Q2 | $127M | Buy |
2,763,246
+62,169
| +2% | +$2.87M | 0.12% | 181 |
|
|
2023
Q1 | $108M | Buy |
2,701,077
+6,635
| +0.2% | +$266K | 0.1% | 193 |
|
|
2022
Q4 | $125M | Sell |
2,694,442
-68,380
| -2% | -$3.17M | 0.12% | 166 |
|
|
2022
Q3 | $114M | Sell |
2,762,822
-74,321
| -3% | -$3.08M | 0.12% | 171 |
|
|
2022
Q2 | $169M | Sell |
2,837,143
-26,778
| -0.9% | -$1.6M | 0.16% | 135 |
|
|
2022
Q1 | $208M | Buy |
2,863,921
+85,062
| +3% | +$6.18M | 0.16% | 143 |
|
|
2021
Q4 | $234M | Buy |
2,778,859
+413,238
| +17% | +$34.7M | 0.16% | 137 |
|
|
2021
Q3 | $213M | Sell |
2,365,621
-4,899
| -0.2% | -$442K | 0.15% | 147 |
|
|
2021
Q2 | $226M | Buy |
2,370,520
+467,125
| +25% | +$44.5M | 0.16% | 143 |
|
|
2021
Q1 | $217M | Buy |
1,903,395
+28,078
| +1% | +$3.2M | 0.16% | 136 |
|
|
2020
Q4 | $260M | Buy |
1,875,317
+96,339
| +5% | +$13.3M | 0.2% | 111 |
|
|
2020
Q3 | $146M | Buy |
1,778,978
+12,416
| +0.7% | +$1.02M | 0.13% | 148 |
|
|
2020
Q2 | $138M | Buy |
1,766,562
+537,252
| +44% | +$42M | 0.12% | 150 |
|
|
2020
Q1 | $54.6M | Buy |
1,229,310
+53,536
| +5% | +$2.38M | 0.06% | 236 |
|
|
2019
Q4 | $50.7M | Sell |
1,175,774
-206,003
| -15% | -$8.88M | 0.04% | 325 |
|
|
2019
Q3 | $59.1M | Buy |
1,381,777
+373,904
| +37% | +$16M | 0.05% | 289 |
|
|
2019
Q2 | $64M | Sell |
1,007,873
-5,400
| -0.5% | -$343K | 0.06% | 266 |
|
|
2019
Q1 | $70.3M | Buy |
1,013,273
+3,237
| +0.3% | +$225K | 0.06% | 250 |
|
|
2018
Q4 | $43.9M | Buy |
1,010,036
+164
| +0% | +$7.13K | 0.04% | 314 |
|
|
2018
Q3 | $77.1M | Buy |
1,009,872
+53,460
| +6% | +$4.08M | 0.07% | 248 |
|
|
2018
Q2 | $73.5M | Buy |
956,412
+161,824
| +20% | +$12.4M | 0.06% | 252 |
|
|
2018
Q1 | $40.5M | Buy |
794,588
+790,168
| +17,877% | +$40.3M | 0.04% | 335 |
|
|
2017
Q4 | $205K | Sell |
4,420
-5
| -0.1% | -$232 | ﹤0.01% | 746 |
|
|
2017
Q3 | $236K | Buy |
4,425
+28
| +0.6% | +$1.49K | ﹤0.01% | 734 |
|
|
2017
Q2 | $273K | Buy |
4,397
+1,622
| +58% | +$101K | ﹤0.01% | 723 |
|
|
2017
Q1 | $188K | Sell |
2,775
-35
| -1% | -$2.37K | ﹤0.01% | 775 |
|
|
2016
Q4 | $198K | Buy |
2,810
+80
| +3% | +$5.64K | ﹤0.01% | 787 |
|
|
2016
Q3 | $194K | Sell |
2,730
-2
| -0.1% | -$142 | ﹤0.01% | 775 |
|
|
2016
Q2 | $134K | Buy |
2,732
+1,510
| +124% | +$74.1K | ﹤0.01% | 800 |
|
|
2016
Q1 | $77K | Buy |
1,222
+1,052
| +619% | +$66.3K | ﹤0.01% | 848 |
|
|
2015
Q4 | $19K | Buy |
+170
| New | +$19K | ﹤0.01% | 982 |
|